
United States of America (USA) General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Description
United States of America (USA) General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
Summary
GlobalData’s “United States General Surgery Device Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States General Surgery Device Procedures. The databook report provides procedure volumes within segments - Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others.
The United States General Surgery Device Procedures report provides key information and data on -
- Procedure volume data for General Surgery Device Procedures related to the country. Data is provided from 2015 to 2030.
United States General Surgery Device Procedures is segmented as follows -
- Airway Stent Procedures
- Bariatric Surgery Procedures
- Biopsy Procedures
- Hernia Repair Procedures
- Prostatectomy Procedures
- Cholecystectomy Procedures
- Colectomy Procedures
- Embolization Particle Procedures
- Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures
- Hysterectomy Procedures
- Myomectomy Procedures
- Percutaneous Drainage Procedures
- Procedures Performed Using External Surgical Stapling Devices
- Procedures Performed Using Internal Surgical Stapling Device
- Prostatectomy Procedures
- Reconstruction Meshes Procedures
United States General Surgery Device Procedures report helps you to develop -
- Business strategies by identifying the key segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Develop investment strategies by identifying the key segments expected to register strong growth in the near future.
Table of Contents
243 Pages
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 General Surgery Devices, Segmentation
- 2.3 Definitions of Procedures Covered in the Report
- 3 General Surgery Devices, United States
- 3.1 General Surgery Devices, United States, 2015-2030
- 3.2 General Surgery Devices, United States, 2015-2030
- 4 Airway Stent Procedures, United States
- 4.1 Airway Stent Procedures, United States, 2015-2030
- 4.1.1 Airway Stenting Procedures for Other Indications, United States, 2015-2030
- 4.1.2 Malignant Airway Obstruction Stenting Procedures, United States, 2015-2030
- 5 Bariatric Surgery Procedures, United States
- 5.1 Bariatric Surgery Procedures, United States, 2015-2030
- 6 Biopsy Procedures, United States
- 6.1 Biopsy Procedures, United States, 2015-2030
- 6.1.1 Biopsy Procedures for Other Indications, United States, 2015-2030
- 6.1.2 Breast Biopsy Procedures, United States, 2015-2030
- 6.1.3 Chronic Kidney Disease Biopsy Procedures, United States, 2015-2030
- 6.1.4 Cirrhosis Biopsy Procedures, United States, 2015-2030
- 6.1.5 Colorectal Biopsy Procedures, United States, 2015-2030
- 6.1.6 Kidney Transplant Biopsy Procedures, United States, 2015-2030
- 6.1.7 Leukemia Biopsy Procedures, United States, 2015-2030
- 6.1.8 Liver Biopsy Procedures, United States, 2015-2030
- 6.1.9 Liver Transplant Biopsy Procedures, United States, 2015-2030
- 6.1.10 Lung Biopsy Procedures, United States, 2015-2030
- 6.1.11 Prostate Biopsy Procedures, United States, 2015-2030
- 6.1.12 Skin Biopsy Procedures, United States, 2015-2030
- 6.1.13 Thyroid Biopsy Procedures, United States, 2015-2030
- 7 Cholecystectomy Procedures, United States
- 7.1 Cholecystectomy Procedures, United States, 2015-2030
- 8 Colectomy Procedures, United States
- 8.1 Colectomy Procedures, United States, 2015-2030
- 9 Embolization Particle Procedures, United States
- 9.1 Embolization Particle Procedures, United States, 2015-2030
- 9.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, United States, 2015-2030
- 9.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, United States, 2015-2030
- 9.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United States, 2015-2030
- 9.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, United States, 2015-2030
- 9.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United States, 2015-2030
- 9.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United States, 2015-2030
- 9.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United States, 2015-2030
- 9.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, United States, 2015-2030
- 9.1.9 Embolization Particle Procedures to treat Uterine Fibroids, United States, 2015-2030
- 10 Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States
- 10.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States, 2015-2030
- 11 Enteral Stenting Procedures, United States
- 11.1 Enteral Stenting Procedures, United States, 2015-2030
- 12 Hernia Repair Procedures, United States
- 12.1 Hernia Repair Procedures, United States, 2015-2030
- 12.1.1 Femoral Hernia Repair Procedures, United States, 2015-2030
- 12.1.2 Incisional Hernia Repair Procedures, United States, 2015-2030
- 12.1.3 Inguinal Hernia Repair Procedures, United States, 2015-2030
- 12.1.4 Other Hernia Repair Procedures, United States, 2015-2030
- 12.1.5 Umbilical Hernia Repair Procedures, United States, 2015-2030
- 13 Hysterectomy Procedures, United States
- 13.1 Hysterectomy Procedures, United States, 2015-2030
- 14 Myomectomy Procedures, United States
- 14.1 Myomectomy Procedures, United States, 2015-2030
- 15 Percutaneous drainage procedures, United States
- 15.1 Percutaneous drainage procedures, United States, 2015-2030
- 15.1.1 Percutaneous drainage procedures for Abscess Drainage, United States, 2015-2030
- 15.1.2 Percutaneous drainage procedures for Biliary Drainage, United States, 2015-2030
- 15.1.3 Percutaneous drainage procedures for Nephrostomy Drainage, United States, 2015-2030
- 15.1.4 Percutaneous drainage procedures for Paracentesis, United States, 2015-2030
- 15.1.5 Percutaneous drainage procedures for Thoracentesis, United States, 2015-2030
- 16 Procedures performed using External Surgical Stapling Devices, United States
- 16.1 Procedures performed using External Surgical Stapling Devices, United States, 2015-2030
- 17 Procedures performed using Internal Surgical Stapling Devices, United States
- 17.1 Procedures performed using Internal Surgical Stapling Devices, United States, 2015-2030
- 17.1.1 Internal Surgical Stapling procedures performed using Open Surgical Stapling Devices, United States, 2015-2030
- 18 Prostatectomy Procedures, United States
- 18.1 Prostatectomy Procedures, United States, 2015-2030
- 19 Reconstruction Meshes Procedures, United States
- 19.1 Reconstruction Meshes Procedures, United States, 2015-2030
- 20 Appendix
- 20.1 Research Methodology
- 20.1.1 Coverage
- 20.1.2 Secondary Research
- 20.1.3 Primary Research
- 20.1.4 Market Modeling and Forecasting
- 20.1.5 Company Share Analysis
- 20.1.6 Distribution Share Analysis
- 20.1.7 Benchmarking
- 20.2 GlobalData Consulting
- 20.3 Contact Us
- 20.4 Disclaimer
- List of Tables
- Table 1: General Surgery Devices, United States, 2015-2030
- Table 2: General Surgery Devices, United States, 2015-2022
- Table 3: General Surgery Devices, United States, 2023-2030
- Table 4: Airway Stent Procedures, United States, 2015-2022
- Table 5: Airway Stent Procedures, United States, 2023-2030
- Table 6: Airway Stenting Procedures for Other Indications, United States, 2015-2022
- Table 7: Airway Stenting Procedures for Other Indications, United States, 2023-2030
- Table 8: Malignant Airway Obstruction Stenting Procedures, United States, 2015-2022
- Table 9: Malignant Airway Obstruction Stenting Procedures, United States, 2023-2030
- Table 10: Bariatric Surgery Procedures, United States, 2015-2022
- Table 11: Bariatric Surgery Procedures, United States, 2023-2030
- Table 12: Biopsy Procedures, United States, 2015-2022
- Table 13: Biopsy Procedures, United States, 2023-2030
- Table 14: Biopsy Procedures for Other Indications, United States, 2015-2022
- Table 15: Biopsy Procedures for Other Indications, United States, 2023-2030
- Table 16: Breast Biopsy Procedures, United States, 2015-2022
- Table 17: Breast Biopsy Procedures, United States, 2023-2030
- Table 18: Chronic Kidney Disease Biopsy Procedures, United States, 2015-2022
- Table 19: Chronic Kidney Disease Biopsy Procedures, United States, 2023-2030
- Table 20: Cirrhosis Biopsy Procedures, United States, 2015-2022
- Table 21: Cirrhosis Biopsy Procedures, United States, 2023-2030
- Table 22: Colorectal Biopsy Procedures, United States, 2015-2022
- Table 23: Colorectal Biopsy Procedures, United States, 2023-2030
- Table 24: Kidney Transplant Biopsy Procedures, United States, 2015-2022
- Table 25: Kidney Transplant Biopsy Procedures, United States, 2023-2030
- Table 26: Leukemia Biopsy Procedures, United States, 2015-2022
- Table 27: Leukemia Biopsy Procedures, United States, 2023-2030
- Table 28: Liver Biopsy Procedures, United States, 2015-2022
- Table 29: Liver Biopsy Procedures, United States, 2023-2030
- Table 30: Liver Transplant Biopsy Procedures, United States, 2015-2022
- Table 31: Liver Transplant Biopsy Procedures, United States, 2023-2030
- Table 32: Lung Biopsy Procedures, United States, 2015-2022
- Table 33: Lung Biopsy Procedures, United States, 2023-2030
- Table 34: Prostate Biopsy Procedures, United States, 2015-2022
- Table 35: Prostate Biopsy Procedures, United States, 2023-2030
- Table 36: Skin Biopsy Procedures, United States, 2015-2022
- Table 37: Skin Biopsy Procedures, United States, 2023-2030
- Table 38: Thyroid Biopsy Procedures, United States, 2015-2022
- Table 39: Thyroid Biopsy Procedures, United States, 2023-2030
- Table 40: Cholecystectomy Procedures, United States, 2015-2022
- Table 41: Cholecystectomy Procedures, United States, 2023-2030
- Table 42: Colectomy Procedures, United States, 2015-2022
- Table 43: Colectomy Procedures, United States, 2023-2030
- Table 44: Embolization Particle Procedures, United States, 2015-2022
- Table 45: Embolization Particle Procedures, United States, 2023-2030
- Table 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United States, 2015-2022
- Table 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United States, 2023-2030
- Table 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United States, 2015-2022
- Table 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United States, 2023-2030
- Table 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United States, 2015-2022
- Table 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United States, 2023-2030
- Table 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United States, 2015-2022
- Table 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United States, 2023-2030
- Table 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United States, 2015-2022
- Table 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United States, 2023-2030
- Table 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United States, 2015-2022
- Table 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United States, 2023-2030
- Table 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United States, 2015-2022
- Table 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United States, 2023-2030
- Table 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United States, 2015-2022
- Table 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United States, 2023-2030
- Table 62: Embolization Particle Procedures to treat Uterine Fibroids, United States, 2015-2022
- Table 63: Embolization Particle Procedures to treat Uterine Fibroids, United States, 2023-2030
- Table 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States, 2015-2022
- Table 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States, 2023-2030
- Table 66: Enteral Stenting Procedures, United States, 2015-2022
- Table 67: Enteral Stenting Procedures, United States, 2023-2030
- Table 68: Hernia Repair Procedures, United States, 2015-2022
- Table 69: Hernia Repair Procedures, United States, 2023-2030
- Table 70: Femoral Hernia Repair Procedures, United States, 2015-2022
- Table 71: Femoral Hernia Repair Procedures, United States, 2023-2030
- Table 72: Incisional Hernia Repair Procedures, United States, 2015-2022
- Table 73: Incisional Hernia Repair Procedures, United States, 2023-2030
- Table 74: Inguinal Hernia Repair Procedures, United States, 2015-2022
- Table 75: Inguinal Hernia Repair Procedures, United States, 2023-2030
- Table 76: Other Hernia Repair Procedures, United States, 2015-2022
- Table 77: Other Hernia Repair Procedures, United States, 2023-2030
- Table 78: Umbilical Hernia Repair Procedures, United States, 2015-2022
- Table 79: Umbilical Hernia Repair Procedures, United States, 2023-2030
- Table 80: Hysterectomy Procedures, United States, 2015-2022
- Table 81: Hysterectomy Procedures, United States, 2023-2030
- Table 82: Myomectomy Procedures, United States, 2015-2022
- Table 83: Myomectomy Procedures, United States, 2023-2030
- Table 84: Percutaneous drainage procedures, United States, 2015-2022
- Table 85: Percutaneous drainage procedures, United States, 2023-2030
- List of Figures
- Figure 1: General Surgery Devices, United States, 2015-2030
- Figure 2: General Surgery Devices, United States, 2015-2022
- Figure 3: General Surgery Devices, United States, 2023-2030
- Figure 4: Airway Stent Procedures, United States, 2015-2022
- Figure 5: Airway Stent Procedures, United States, 2023-2030
- Figure 6: Airway Stenting Procedures for Other Indications, United States, 2015-2022
- Figure 7: Airway Stenting Procedures for Other Indications, United States, 2023-2030
- Figure 8: Malignant Airway Obstruction Stenting Procedures, United States, 2015-2022
- Figure 9: Malignant Airway Obstruction Stenting Procedures, United States, 2023-2030
- Figure 10: Bariatric Surgery Procedures, United States, 2015-2022
- Figure 11: Bariatric Surgery Procedures, United States, 2023-2030
- Figure 12: Biopsy Procedures, United States, 2015-2022
- Figure 13: Biopsy Procedures, United States, 2023-2030
- Figure 14: Biopsy Procedures for Other Indications, United States, 2015-2022
- Figure 15: Biopsy Procedures for Other Indications, United States, 2023-2030
- Figure 16: Breast Biopsy Procedures, United States, 2015-2022
- Figure 17: Breast Biopsy Procedures, United States, 2023-2030
- Figure 18: Chronic Kidney Disease Biopsy Procedures, United States, 2015-2022
- Figure 19: Chronic Kidney Disease Biopsy Procedures, United States, 2023-2030
- Figure 20: Cirrhosis Biopsy Procedures, United States, 2015-2022
- Figure 21: Cirrhosis Biopsy Procedures, United States, 2023-2030
- Figure 22: Colorectal Biopsy Procedures, United States, 2015-2022
- Figure 23: Colorectal Biopsy Procedures, United States, 2023-2030
- Figure 24: Kidney Transplant Biopsy Procedures, United States, 2015-2022
- Figure 25: Kidney Transplant Biopsy Procedures, United States, 2023-2030
- Figure 26: Leukemia Biopsy Procedures, United States, 2015-2022
- Figure 27: Leukemia Biopsy Procedures, United States, 2023-2030
- Figure 28: Liver Biopsy Procedures, United States, 2015-2022
- Figure 29: Liver Biopsy Procedures, United States, 2023-2030
- Figure 30: Liver Transplant Biopsy Procedures, United States, 2015-2022
- Figure 31: Liver Transplant Biopsy Procedures, United States, 2023-2030
- Figure 32: Lung Biopsy Procedures, United States, 2015-2022
- Figure 33: Lung Biopsy Procedures, United States, 2023-2030
- Figure 34: Prostate Biopsy Procedures, United States, 2015-2022
- Figure 35: Prostate Biopsy Procedures, United States, 2023-2030
- Figure 36: Skin Biopsy Procedures, United States, 2015-2022
- Figure 37: Skin Biopsy Procedures, United States, 2023-2030
- Figure 38: Thyroid Biopsy Procedures, United States, 2015-2022
- Figure 39: Thyroid Biopsy Procedures, United States, 2023-2030
- Figure 40: Cholecystectomy Procedures, United States, 2015-2022
- Figure 41: Cholecystectomy Procedures, United States, 2023-2030
- Figure 42: Colectomy Procedures, United States, 2015-2022
- Figure 43: Colectomy Procedures, United States, 2023-2030
- Figure 44: Embolization Particle Procedures, United States, 2015-2022
- Figure 45: Embolization Particle Procedures, United States, 2023-2030
- Figure 46: Embolization Particle Procedures to treat Arteriovenous Malformations, United States, 2015-2022
- Figure 47: Embolization Particle Procedures to treat Arteriovenous Malformations, United States, 2023-2030
- Figure 48: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United States, 2015-2022
- Figure 49: Embolization Particle Procedures to treat Benign prostatic hyperplasia, United States, 2023-2030
- Figure 50: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United States, 2015-2022
- Figure 51: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, United States, 2023-2030
- Figure 52: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United States, 2015-2022
- Figure 53: Embolization Particle Procedures to treat Hepatocellular Carcinoma, United States, 2023-2030
- Figure 54: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United States, 2015-2022
- Figure 55: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, United States, 2023-2030
- Figure 56: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United States, 2015-2022
- Figure 57: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, United States, 2023-2030
- Figure 58: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United States, 2015-2022
- Figure 59: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, United States, 2023-2030
- Figure 60: Embolization Particle Procedures to treat Renal Cell Carcinoma, United States, 2015-2022
- Figure 61: Embolization Particle Procedures to treat Renal Cell Carcinoma, United States, 2023-2030
- Figure 62: Embolization Particle Procedures to treat Uterine Fibroids, United States, 2015-2022
- Figure 63: Embolization Particle Procedures to treat Uterine Fibroids, United States, 2023-2030
- Figure 64: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States, 2015-2022
- Figure 65: Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) procedures, United States, 2023-2030
- Figure 66: Enteral Stenting Procedures, United States, 2015-2022
- Figure 67: Enteral Stenting Procedures, United States, 2023-2030
- Figure 68: Hernia Repair Procedures, United States, 2015-2022
- Figure 69: Hernia Repair Procedures, United States, 2023-2030
- Figure 70: Femoral Hernia Repair Procedures, United States, 2015-2022
- Figure 71: Femoral Hernia Repair Procedures, United States, 2023-2030
- Figure 72: Incisional Hernia Repair Procedures, United States, 2015-2022
- Figure 73: Incisional Hernia Repair Procedures, United States, 2023-2030
- Figure 74: Inguinal Hernia Repair Procedures, United States, 2015-2022
- Figure 75: Inguinal Hernia Repair Procedures, United States, 2023-2030
- Figure 76: Other Hernia Repair Procedures, United States, 2015-2022
- Figure 77: Other Hernia Repair Procedures, United States, 2023-2030
- Figure 78: Umbilical Hernia Repair Procedures, United States, 2015-2022
- Figure 79: Umbilical Hernia Repair Procedures, United States, 2023-2030
- Figure 80: Hysterectomy Procedures, United States, 2015-2022
- Figure 81: Hysterectomy Procedures, United States, 2023-2030
- Figure 82: Myomectomy Procedures, United States, 2015-2022
- Figure 83: Myomectomy Procedures, United States, 2023-2030
- Figure 84: Percutaneous drainage procedures, United States, 2015-2022
- Figure 85: Percutaneous drainage procedures, United States, 2023-2030
- Figure 86: Percutaneous drainage procedures for Abscess Drainage, United States, 2015-2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.